Study Objectives: In the 2014 epidemic of West Nile virus infection in Orange County, California, there were 198 reported cases of West Nile neuroinvasive disease (WNND) which is the highest number ever reported in 1 U.S. county in any 1 year. We hypothesized that factors determining a poor outcome (death or disability) could be predicted from information available in the emergency department at presentation prior to hospital admission.
Methods: West Nile virus infection is a reportable disease in California. The Orange County Health Care Agency (OCHCA) collected detailed information on the 198 persons reported with WNND in 2014. We retrospectively reviewed all cases in the OCHCA database. All cases were confirmed by molecular and/or serologic testing. We reviewed medical history, clinical manifestations and laboratory data to determine what factors, if any, were predictive of mortality or disability. We used death or discharge to a skilled nursing, rehab or subacute care facility as indicative of a more severe course. IBM SPSS Statistics 25 was used for data analysis. Continuous variables are presented as meanAEstandard deviation (SD), and were compared among groups by using student's t test, or median test if necessary. Frequencies are presented as percentage (95% confidence interval) and were compared among groups by using chi square or Fisher exact test if necessary.
Results: Eight patients (4.0%) died during the hospital admission and 36 (18.2%) were discharged to a facility. Mean age of deceased patients was 74.3AE13.25 years compared to 52.3AE17.6 years for survived patients (P¼ 0.001). Patients were hospitalized for an average 8.6AE6.9 days (range: 1-61, median¼6.0). Twenty patients were admitted to an ICU for an average of 13.2AE11.5 days (range: 1-53, median¼9.5). Advanced age as well as initial higher serum creatinine, BUN and lower platelet count were associated with increased risk of death (P<0.05 for each). Mortality in patients with cancer or chronic kidney disease (CKD) was 14.3% compared to 2.8% in patients without such a history (OR: 5.73, P¼0.01). Neither initial serum sodium level nor initial Glasgow coma scale<15 were predictive of death or disability.
Conclusions: There is no rapid test available in the ED to identify West Nile virus. Confirmation of the diagnosis by molecular and serologic testing can take many days. Treatment is only supportive. Factors associated with increased risk of death or disability can be determined at the time of the patient's initial presentation in the ED. Utilizing this information in clinical decisionmaking, such as admission to a specialized neurologic intensive care unit for high risk patients, may lead to improved outcomes in the next epidemic. Wisconsin expanded eligibility in April, 2014 to include childless adults up to 100% of the federal poverty line (FPL), but not as part of the ACA. Arizona, Iowa, and Kentucky all expanded eligibility in January, 2014 to include childless adults up to 133% of the FPL under the terms of the ACA. Sample statistics including demographics, admission rates, and advanced cardiac imaging (any one of and each individually among stress electrocardiogram, stress echocardiogram, coronary CT angiography, myocardial perfusion imaging) were tabulated by state and year. Difference-in-differences models including visit-level covariates (age, sex, insurance status, income, race) were used to estimate the effect of Medicaid eligibility expansion on likelihood that a given Medicaid ED visit after eligibility expansion will result in: hospital admission and advanced cardiac imaging. A subgroup analysis limited to ED visits with a principal diagnosis of unspecified chest pain was also performed to further explore resource utilization changes.
Results: The Table shows adjusted odds ratios for each of our outcomes among all ED visits and limited to chest pain visits. There were approximately 11.6 million ED visits in the sample and 196,217 chest pain visits. The proportion of ED visits that were primarily self-pay fell in all 5 states in the period from January 2013 to December 2014. The changes were most pronounced in those states that expanded Medicaid eligibility. In difference-indifferences analysis, Medicaid expansion was associated with small increases in the odds of admission (OR 1.03 [95% CI 1.01 to 1.05]) and any advanced cardiac imaging (OR 1.24 [95% CI 1.12 to 1.36]) among all ED visits, and admission (OR 1.25 [95% CI 1.01 to 1.54]) but not imaging in the chest pain subset. This corresponds to an additional admission for every 400 ED visits and an additional imaging test for every 165 ED visits.
Conclusions: In this analysis of data from 5 states, Medicaid eligibility expansion was associated with small increases in admission rates and advanced cardiac imaging use. Whether this reflects a change in patient mix or a response to altered payment incentives is not known.
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